Effectiveness of rivastigmine in Alzheimer's disease. Guidelines do not ignore clinically relevant end points.
Storosum
J G
JG
van Zwieten-Boot
B J
BJ
Elferink
A J
AJ
D000544:Alzheimer Disease / Q000188:drug therapy*; D002219:Carbamates / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D048448:Phenylcarbamates; D017410:Practice Guidelines as Topic; D000068836:Rivastigmine
D002219:Carbamates; D002800:Cholinesterase Inhibitors; D048448:Phenylcarbamates; D000068836:Rivastigmine